The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

GSK GLAXOSMITHKLINE PLC ORD 25P



Income Statement  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
Revenue  27387.00 26431.00 26505.00 23006.00 23923.00
Operating Profit/(Loss)  7807.00 7300.00 7028.00 3597.00 10322.00
Net Interest  744.00 745.00 726.00 688.00 719.00
Profit Before Tax  7698.00 6600.00 6647.00 2968.00 10526.00
Profit After Tax  5458.00 4678.00 5628.00 2831.00 8372.00
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  5458.00 4678.00 5628.00 2831.00 8372.00
Attributable to:
Minority Interests  -197.00 -179.00 -192.00 -75.00 50.00
Equity Holders of Parent Company  5261.00 4499.00 5436.00 2756.00 8422.00
 
Continuing EPS
Earnings per Share - Basic  104.60p 91.60p 112.50p 57.30p 174.30p
Earnings per Share - Diluted  103.20p 90.20p 110.50p 56.70p 172.30p
Earnings per Share - Adjusted  104.60p 111.40p 108.40p 95.40p 75.70p
Continuing and Discontinued EPS
Earnings per Share - Basic  104.60p 91.60p 112.50p 57.30p 174.30p
Earnings per Share - Diluted  103.20p 90.20p 110.50p 56.70p 172.30p
Earnings per Share - Adjusted  104.60p 111.40p 108.40p 95.40p 75.70p
 
Dividend per Share  67.00p 72.00p 76.00p 80.00p 80.00p

Balance Sheet  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Assets
Non-Current Assets
Property, Plant & Equipment  6656.00 6835.00 6355.00 6671.00 6998.00
Intangible Assets  11556.00 14520.00 13488.00 12044.00 21834.00
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  1150.00 1366.00 1525.00 1454.00 1462.00
Other Financial Assets  85.00 54.00 1.00 0.00 0.00
Other Non-Current Assets  5466.00 5014.00 5490.00 5804.00 6565.00
  24913.00 27789.00 26859.00 25973.00 36859.00
Current Assets
Inventories  3873.00 3969.00 3900.00 4231.00 4716.00
Trade & Other Receivables  5661.00 5345.00 5571.00 4738.00 5795.00
Cash at Bank & in Hand  5714.00 4184.00 5534.00 4338.00 5830.00
Current Asset Investments  254.00 130.00 221.00 215.00 200.00
Other Current Assets  665.00 64.00 1.00 1156.00 46.00
  16167.00 13692.00 15227.00 14678.00 16587.00
 
Total Assets  41080.00 41481.00 42086.00 40651.00 53446.00
 
Liabilities
Current Liabilities
Borrowings  -2698.00 -3631.00 -2789.00 -2943.00 -1308.00
Other Current Liabilities  -12312.00 -10184.00 -10888.00 -10352.00 -12109.00
  -15010.00 -13815.00 -13677.00 -13295.00 -13417.00
 
Net Current Assets  1157.00 -123.00 1550.00 1383.00 3170.00
 
Non-Current Liabilities
Borrowings  -12203.00 -14671.00 -15456.00 -15841.00 -15324.00
Provisions  -1321.00 -1703.00 -1245.00 -990.00 -1942.00
Other Non-Current Liabilities  -3719.00 -4555.00 -3896.00 -5589.00 -13885.00
  -17243.00 -20929.00 -20597.00 -22420.00 -31151.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -32253.00 -34744.00 -34274.00 -35715.00 -44568.00
 
Net Assets  8827.00 6737.00 7812.00 4936.00 8878.00
 
Capital & Reserves
Share Capital  1387.00 1349.00 1336.00 1339.00 1340.00
Share Premium Account  1673.00 2022.00 2595.00 2759.00 2831.00
Other Reserves  1602.00 1787.00 2153.00 2239.00 2340.00
Retained Earnings  3370.00 642.00 913.00 -2074.00 -1397.00
Shareholders Funds  8032.00 5800.00 6997.00 4263.00 5114.00
 
Minority Interests/Other Equity  795.00 937.00 815.00 673.00 3764.00
Total Equity  8827.00 6737.00 7812.00 4936.00 8878.00

Ratios - based on IFRS 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
PE Ratio - Adjusted  14.07 11.98 14.87 14.42 18.14
PEG - Adjusted  0.15 1.84 -5.53 -1.20 -0.88
Earnings per Share Growth - Adjusted  94.06% 6.50% -2.69% -11.99% -20.65%
Dividend Cover  1.56 1.55 1.43 1.19 0.95
Revenue Per Share  544.69p 538.09p 548.64p 478.49p 495.20p
Pre-Tax Profit per Share  153.10p 134.36p 137.59p 61.73p 217.88p
Operating Margin  30.83% 27.45% 28.34% 20.22% 54.74%
Return on Capital Employed  50.90% 47.87% 46.07% 23.07% 127.11%
 
Continuing & Discontinued Operations
Dividend Yield  4.55% 5.39% 4.72% 5.81% 5.83%
Dividend per Share Growth  6.35% 7.46% 5.56% 5.26% 0.00%
Net Asset Value per Share (exc. Intangibles)  -69.80p -177.86p -133.70p -159.98p -343.34p
Net Gearing  114.38% 243.41% 181.66% 338.87% 211.22%

Data is provided by Morningstar



Company Information
Updated Monthly
Company address C8 Gsk House, 980 Great West Road, Brentford, TW8 9GS, United Kingdom
Company website http://www.gsk.com
Market cap(in millions)* £ 70,227.84
Listing/Admission to trading 22 May 1972
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
25-May-16
FTSE index FTSE techMARK All-Share,FTSE All-Share,FTSE Eurotop 300,FTSE 350,FTSE All-Share (ex IT),FTSE 350 (ex IT),FTSE 100,FTSE 350 High Yield
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 1,500
SEDOL 0925288
ISIN number GB0009252882



GLAXOSMITHKLINE share fundamentals (GSK)